Abstract
Driving Stem Cell Technology Forward – Stem Cell Sciences In-licenses Technology from University of Cambridge for Reprogramming Adult Cells into Stem Cells. The Latest State-of-the-art Clinical Trial Supply Service Center Opens in China. Charles River Strengthens Its Presence in China. In the Making – China Biologic to Become Largest Non-state-owned Producer of Plasma-based Products in China. Joint Venture between Eli Lilly and Jubilant Organosys Boosts Development of Molecules. From Discovery to Delivery – Orchid & Merck Collaborate to Develop Novel Anti-infective Drugs. New Standard for Early Diagnosis of Urinary Bladder Cancer Launched. Gene Bridges Granted Licenses to Takeda Pharmaceuticals Licenses for Recombineering Technology. East-West Collaboration to Develop Therapeutics for Fully-human Antibody Program. The Kiwis Open Commercialization Pathway into the Land of Dragons. Innovative Institute-Industry Partnership in Translational Cancer Research. Singapore to be the Takeda's Center of Clinical Development. First South-east Asian Hub for Solar PV Testing and Certification Opens in Singapore.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
